You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Biogen
since
auto-detected in 13 stories
12 days ago
Biogen could see more upside if it publishes positive results from recent trials linked to kidney and Alzheimer's treatments, Truist Securities says.
Here are Monday's biggest analyst calls: Nvidia, SpaceX, Tesla, Apple, Netflix, Deckers, Biogen, Nio & more ○
found
Here are Monday's biggest calls on Wall Street.
72 days ago
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data ○
Biogen said signals sugget the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.
Stocks making the biggest moves premarket: Versant, Biogen, Bullish, Cisco and more ○
These are the stocks posting the largest moves in the premarket.
3 months ago
Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Microsoft, Amazon, Ulta Beauty, Okta, Biogen, Meta & more ⊕
found
Here are the biggest calls on Wall Street on Monday.
This biotech firm has room to run, even as its drug royalties are set to shrink ⊕
Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will support its growth, per Piper Sandler.
Biogen to buy Apellis Pharmaceuticals for $5.6 billion to expand its rare disease portfolio ⊕
Biogen has agreed to acquire Apellis Pharmaceuticals for about $5.6 billion in cash, expanding its portfolio of rare-disease medicines.
6 months ago
Stocks making the biggest moves midday: Biogen, Rivian, Bank of America, Airbnb & more ○
These are the stocks posting the largest moves in midday trading.
8 months ago
Stifel upgrades biotech stock on a narrative shift in Alzheimer’s treatment ○
Stifel sees Biogen stock rallying nearly 32% from here.
10 months ago
Stocks making the biggest moves midday: Frontier Group, Kraft Heinz, Biogen and more ○
These are the stocks posting the largest moves in midday trading.